全文获取类型
收费全文 | 2904篇 |
免费 | 199篇 |
国内免费 | 19篇 |
专业分类
耳鼻咽喉 | 16篇 |
儿科学 | 45篇 |
妇产科学 | 12篇 |
基础医学 | 405篇 |
口腔科学 | 105篇 |
临床医学 | 165篇 |
内科学 | 783篇 |
皮肤病学 | 26篇 |
神经病学 | 327篇 |
特种医学 | 56篇 |
外科学 | 549篇 |
综合类 | 18篇 |
预防医学 | 113篇 |
眼科学 | 23篇 |
药学 | 219篇 |
中国医学 | 9篇 |
肿瘤学 | 251篇 |
出版年
2023年 | 18篇 |
2022年 | 38篇 |
2021年 | 69篇 |
2020年 | 34篇 |
2019年 | 48篇 |
2018年 | 62篇 |
2017年 | 50篇 |
2016年 | 60篇 |
2015年 | 61篇 |
2014年 | 73篇 |
2013年 | 101篇 |
2012年 | 155篇 |
2011年 | 187篇 |
2010年 | 115篇 |
2009年 | 87篇 |
2008年 | 148篇 |
2007年 | 195篇 |
2006年 | 167篇 |
2005年 | 196篇 |
2004年 | 189篇 |
2003年 | 173篇 |
2002年 | 190篇 |
2001年 | 58篇 |
2000年 | 45篇 |
1999年 | 51篇 |
1998年 | 42篇 |
1997年 | 38篇 |
1996年 | 22篇 |
1995年 | 28篇 |
1994年 | 26篇 |
1993年 | 23篇 |
1992年 | 52篇 |
1991年 | 43篇 |
1990年 | 45篇 |
1989年 | 27篇 |
1988年 | 37篇 |
1987年 | 29篇 |
1986年 | 17篇 |
1985年 | 11篇 |
1984年 | 6篇 |
1983年 | 14篇 |
1982年 | 7篇 |
1981年 | 10篇 |
1980年 | 8篇 |
1979年 | 12篇 |
1977年 | 5篇 |
1976年 | 6篇 |
1975年 | 5篇 |
1974年 | 5篇 |
1971年 | 6篇 |
排序方式: 共有3122条查询结果,搜索用时 15 毫秒
101.
102.
103.
Kubo N Narumi S Kijima H Mizukami H Yagihashi S Hakamada K Nakane A 《Journal of gastroenterology and hepatology》2012,27(1):165-172
Background and Aim: Fulminant hepatitis is mainly caused by excessive immune response‐mediated liver injury and its definitive therapy is liver transplantation. Mesenchymal stem cells, one of the adult stem cells, have an immunomodulatory effect on immune cells and reside in various tissues. The aim of this study was to investigate a therapeutic effect of adipose tissue‐derived mesenchymal stem cells (ASCs) on fulminant hepatitis induced by concanavalin A (ConA). Methods: The ASCs were isolated from adipose tissues of BALB/c mice and confirmed by detection of cell surface markers and induction of multi‐lineage differentiation. BALB/c mice were injected with ConA and treated with ASCs, phosphate buffered saline (PBS) or splenocytes (SPLCs). Survival rates, levels of serum liver enzymes, titers of serum cytokines, histopathology and localization of ASCs were investigated. Result: The survival rate of ASC‐injected mice significantly increased compared to PBS or SPLC‐injected mice. This effect was dependent on doses and timing of ASCs injected. Improvement of liver enzyme levels, histopathological changes and suppression of inflammatory cytokine production were observed in ASC‐injected mice. Fluorescent stained ASCs were detected in inflammatory liver, but not in normal liver. Conclusion: These results suggest that ASC treatment has a high potential to be an innovative therapy for fulminant hepatitis. 相似文献
104.
105.
Takata Y Kikukawa M Hanyu H Koyama S Shimizu S Umahara T Sakurai H Iwamoto T Ohyashiki K Ohyashiki JH 《The journals of gerontology. Series A, Biological sciences and medical sciences》2012,67(4):330-335
Although several reports suggest that Alzheimer's disease (AD) is associated with shortened telomere length, the clinical relevance of this has not yet been fully elucidated. This study was conducted to clarify the correlation of telomere length with clinical characteristics and ApoE phenotypes in 74 AD patients. Telomere length was determined from genomic DNA extracted from whole blood by quantitative real-time polymerase chain reaction. We found no significant difference in telomere length between the AD and non-dementia elderly control (n = 35) groups. Furthermore, no significant correlation was found among telomere length and the severity of cognitive decline and disease duration, age, or gender difference. However, telomere length was significantly shorter in AD patients with the ApoE4 homozygote than in those with the ApoE4 heterozygote (p < .001) and noncarriers (p < .001). These findings suggest that shortened telomere length may be associated with the ApoE4 homozygote in AD patients. 相似文献
106.
107.
Takeuchi T Tanaka Y Kaneko Y Tanaka E Hirata S Kurasawa T Kubo S Saito K Shidara K Kimura N Nagasawa H Kameda H Amano K Yamanaka H 《Modern rheumatology / the Japan Rheumatism Association》2012,22(3):327-338
We retrospectively investigated the ability of adalimumab (ADA) to reduce disease activity, improve physical function, and retard the progression of structural damage in 167 patients with rheumatoid arthritis. Clinical and functional outcomes were compared between patients with or without prior biologic treatment and those with or without concomitant methotrexate (MTX) treatment. At week 52, 38.3% achieved clinical remission: 42.4 and 28.6% of patients achieved remission in those without and with previous biologics, respectively, while 42.7 and 12.5% of patients achieved remission in those with and without concomitant MTX, respectively. ADA treatment significantly reduced the rate of radiographic progression from 27.1 ± 46.0 (median 13.6; 25th-75th percentiles 8.3 to 28.9) at baseline to 0.8 ± 5.0 (median 0.0; 25th-75th percentiles -0.9 to 2.0) at week 52 (P < 0.0001). Radiographic progression was absent in 59.8% of patients. Sixty adverse events (34.21/100 patient-years) were reported, 16 of which were serious (9.12/100 patient-years). ADA therapy is highly effective for reducing disease activity, improving physical function, and limiting radiographic progression. It is generally safe and well tolerated by Japanese RA patients in routine clinical practice. 相似文献
108.
Jun Takahashi Hirokazu Kobayashi Shinji Wakabayashi Masao Deguchi Hidehiro Ito Yuji Mogami Hirotaka Tanikawa Hiroyuki Nakagawa Hideki Moriya Ryohei Ashizawa Kenji Takahara Hisatoshi Kinoshita Yutaka Tateiwa Hiromichi Misawa Takahiro Tsutsumimoto Taku Nakakohji Yohei Yuzawa Akihito Sawaumi Yohei Hidai Satoshi Matsuda Isao Nakamura Shigeyuki Toba Mikio Kamimura Takeshi Nakane Hiroki Hirabayashi Hiroyuki Hashidate Nobuhide Ogihara Keijiro Mukaiyama Hiroyuki Kato Kuniyoshi Ohtsuka 《Journal of orthopaedic science》2013,18(2):208-215
Background
Quality of life (QOL) is a concern for patients with lumbar spinal stenosis (LSS). In this study, QOL was examined using the 5-item EuroQol (EQ-5D).Methods
QOL and activities of daily living (ADL) were surveyed for 91 patients who visited 18 medical institutions in our prefecture and were diagnosed with LSS-associated intermittent claudication. A second survey was performed after ≥6 weeks for 79 of the subjects to evaluate therapy with limaprost (an oral prostaglandin E1 derivative) or etodolac (an NSAID). Symptoms, maximum walking time, QOL, ADL items, and relationships among these variables were investigated for all 91 patients. Leg pain, leg numbness, and low back pain while walking were surveyed by use of VAS scores (0–100).Results
Leg pain, leg numbness, and low back pain while walking (VAS ≥25) were present in 83.5, 62.6, and 54.9 % of the patients in the first survey, and approximately half of the patients had a maximum walking time <15 min. The mean EQ-5D utility value for QOL was 0.59 ± 0.12. This value was significantly associated with maximum walking time (p = 0.030) based on classification of patients into groups with walking times <7.5, 7.5–15, 15–30, and >30 min, showing that maximum walking time affected health-related QOL. Of the 79 patients who completed the second survey, 56 had taken limaprost and 23 (control group) had received etodolac. Limaprost improved possible walking time, reduced ADL interference, and significantly increased the EQ-5D utility score, whereas no significant changes occurred in the control group. Maximum walking time was prolonged by ≥10 min and the EQ-5D utility value was improved by ≥0.1 points in significantly more patients in the limaprost group than in the control group.Conclusion
According to the findings of this survey, at an average of 8 weeks after administration limaprost improved symptoms, QOL, and ADL in LSS patients whereas treatment with an NSAID reduced pain but did not have any other effects. 相似文献109.
Kenichi Oe Hirokazu Iida Tomohisa Nakamura Naofumi Okamoto Takahiko Wada 《Archives of orthopaedic and trauma surgery》2013,133(12):1763-1770
Background
Total hip arthroplasty (THA) is a challenging surgical procedure that can be used to treat severely dislocated hips. There are few reports regarding cemented THAs involving subtrochanteric shortening osteotomy (SSO), even though cemented THAs provide great advantages because the femur is generally hypoplastic with a narrow, deformed canal.Purposes
We evaluated the utility of cemented THA with SSO for Crowe group IV hips, and assessed the relationship between leg lengthening and nerve injury. Our goal was to describe surgical techniques for optimizing surgical outcomes while minimizing the risk of nerve injury.Methods
We retrospectively reviewed 34 cases of cemented THAs with transverse SSO for Crowe group IV. Prior to surgery, mean hip flexion was 93.1° (40°–130°). The mean follow-up period was 5.2 years (3–10 years).Results
Bone union took an average of 7.7 months (3–24 months). Mean leg lengthening was 40.5 mm (15–70 mm) and was greater in patients without hip flexion contracture. None of the patients experienced any nerve injuries associated with leg lengthening, and radiographic evidence of loosening was not observed at the final follow-up.Conclusions
SSO combined with cemented THA is an effective treatment for severely dislocated hips. Leg lengthening is not necessarily associated with nerve injuries, and the likelihood of this surgical complication may be related to the presence of hip flexion contracture. 相似文献110.
Yuichiro Hashida Satoshi Yasukochi Kiyohiro Takigiku Tesshu Otagiri Nao Inoue Yusuke Nakano Kohta Takei Yoshiyuki Maekawa Kentaro Umezu Takahiko Sakamoto Yorikazu Harada 《Journal of Echocardiography》2013,11(2):66-68
Aortic arch thrombosis (AAT) of the neonate is rare but life-threatening by fatal compromise associated with thrombotic obstruction of the ascending aorta. We report a neonate with AAT who demonstrated a severe coarctation of the aorta and cerebral hypo-perfusion immediately after birth. Echocardiography confirmed the diagnosis of AAT on the findings of a large thrombus located on the transverse arch and blocking the cervical arterial branches. Low-molecular-weight heparin reduced the size of the thrombus and improved the hemodynamics of coarctation and cerebral perfusion. Echocardiography is a powerful tool to make a diagnosis and to monitor the size and regression of AAT. 相似文献